Brief: Telesis Bio Inc - On June 6 Received Nasdaq Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard Transfer Of Listing
12/06/2024 22:37
Telesis Bio Inc TBIO.O :
* TELESIS BIO INC - ON JUNE 6 RECEIVED NASDAQ NOTICE OF
DELISTING
OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD;
TRANSFER OF LISTING
Source text for Eikon: ID:n0000950170-24-072532
Further company coverage: TBIO.O
Recent news on Telesis Bio
See all newsBrief: Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
Brief: Telesis Bio Plans To Delist Its Securities From The Nasdaq Stock Market
Brief: Telesis Bio Says Co Entered Share Purchase Agreement With Yuan Yang To Sell All Of Outstanding Capital Stock Of Eton Bio
Telesis Bio Inc reports results for the quarter ended in June - Earnings Summary
Telesis Bio Inc expected to post a loss of $4.03 a share - Earnings Preview